Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Mar 10, 2009

Premium

Kevin Ulmer has completed his three-month full-time consulting project for Complete Genomics and has returned to Massachusetts, where he is the CEO of Really Tiny Stuff.


Patrick Soon-Shiong has become chairman of the life sciences prize group steering committee of the X Prize Foundation. He is the chairman and CEO of Abraxis BioScience.


Shaun Lonergan has become CEO of Nerites, which develops new wound adhesives, and has joined the company's board of directors. Most recently, he was vice president of sales, marketing, and business development for Ibis Biosciences, which was sold to Abbott Molecular in January. Prior to that, he held "similar executive positions" at 454 Life Sciences and NimbleGen Systems. Earlier, he was vice president of corporate development at Third Wave Technologies.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.